EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris

EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris (September 2023, partial update February 2025) - European Dermatology Forum (EDF) 

Scope and purpose of this guideline
The overall aim of this guideline is to provide guidance for optimal treatment selection and management in the treatment of adults with moderate to severe plaque type psoriasis. Optimal treatment selection and management are meant to reduce morbidity caused by psoriasis and to improve the health related quality of life of affected individuals.

The objectives of the guideline are to:
- Include new treatments and the evidence that has become available
- Update the recommendations regarding biologic systemic treatment options
- Develop a treatment algorithm including biologic and nonbiologic systemic treatment options
- Provide clear recommendations on how to best monitor and manage patients considering the available treatment options
- Develop several short guidance documents with visual tools for ease of implementation
- Provide guidance on the treatment of special populations and difficult clinical situations (mostly expert consensus)


Read full Guideline